The Types segment classifies cell culture media into serum‑based, serum‑free, and chemically defined formulations. Serum‑based media, still used in early‑stage R&D, contributes roughly 20 % of total spend, reflecting legacy protocols and limited scalability. Serum‑free media, which replaces animal‑derived components with plant‑based or recombinant proteins, commands about 45 % of the market as it balances performance with regulatory acceptance. Chemically defined media—comprising fully synthetic, reproducible ingredients—captures the remaining 35 % and is favored for large‑scale manufacturing due to consistency, reduced contamination risk, and alignment with clean‑label claims. The shift toward serum‑free and chemically defined options drives overall market growth by enabling higher production volumes, lower cost of goods, and broader consumer acceptance, reinforcing the importance of precise market taxonomy in strategic planning.